Update: recommendations from the Advisory Committee on Immunization Practices (ACIP) regarding administration of
Insights
The combination measles, mumps, rubella, and varicella (MMRV) vaccine may increase the risk of febrile seizures in young children. The Advisory Committee on Immunization Practices (ACIP) updated recommendations to no longer prefer MMRV over separate vaccines.
Area of Science:
- Pediatric Vaccinology
- Immunology
- Public Health
Background:
- The combination measles, mumps, rubella, and varicella (MMRV) vaccine (ProQuad) was developed for convenient administration.
- Concerns have been raised regarding the risk of febrile seizures in children following MMRV vaccination.
- The Advisory Committee on Immunization Practices (ACIP) previously recommended MMRV over separate vaccines.
Purpose of the Study:
- To summarize current knowledge on the risk of febrile seizures associated with MMRV vaccination.
- To present updated ACIP recommendations based on new safety information.
- To inform healthcare providers and the public about vaccine safety and recommendations.
Main Methods:
- Review of existing data and new information presented to ACIP.
- Analysis of the risk for febrile seizures in children aged 12-23 months after MMRV vaccination.
- Development of updated immunization recommendations.
Main Results:
- New information indicated a risk for febrile seizures among children aged 12-23 months after MMRV vaccination.
- The updated recommendations address the safety profile of the MMRV vaccine.
- The previous preference for MMRV over separate vaccines was removed.
Conclusions:
- The ACIP has revised its recommendations regarding the MMRV vaccine.
- The updated guidance reflects a shift away from preferring the combination vaccine due to safety concerns.
- Separate administration of measles, mumps, and rubella (MMR) vaccine and varicella vaccine is now an alternative to consider.
Abstract:
On February 27, 2008, new information was presented to the Advisory Committee on Immunization Practices (ACIP) regarding the risk for febrile seizures among children aged 12-23 months after administration of the combination measles, mumps, rubella, and varicella (MMRV) vaccine (ProQuad, Merck & Co., Inc., Whitehouse Station, New Jersey). This report summarizes current knowledge regarding the risk for febrile seizures after MMRV vaccination and presents updated ACIP recommendations that were issued after presentation of the new information. These updated recommendations remove ACIP's previous preference for administering combination MMRV vaccine over separate injections of equivalent component vaccines (i.e., measles, mumps, and rubella [MMR] vaccine and varicella vaccine).
Related Concept Videos
Vaccinations
Respiratory Syncytial Virus Disease
Smallpox
Microorganisms in Medicine and Therapeutics
Vaccines
Drug Dosing: Infants and Children


